Viremia Negativization After BK Virus Infection in Kidney Transplantation: A National Bicentric Study-Reference-Cited by-同舟云学术

Viremia Negativization After BK Virus Infection in Kidney Transplantation: A National Bicentric Study

Published:2019-11 Issue:9 Volume:51 Page:2936-2938
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Garofalo Manuela,Pisani Francesco,Lai Quirino,Montali Filippo,Nudo Francesco,Gaeta Aurelia,Russo Gianluca,Natilli Andrea,Poli Luca,Martinelli Caterina,Binda Barbara,Pretagostini Renzo

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference18 articles.

1. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients;Hirsch;N Engl J Med,2002

2. New England BK consortium: regional survey of BK screening and management protocols in comparison to published consensus guidelines;Gabardi;Transpl Infect Dis,2018

3. KDIGO clinical practice guideline for the care of kidney transplant recipients;Am J Transplant,2009

4. Risk factors for BK virus viremia and nephropathy after kidney transplantation: a systematic review;Demey;J Clin Virol,2018

5. BK virus nephropathy in kidney transplantation: an approch proposal and update on risk factors, diagnosis and treatment;Gonzalez;Transplant Proc,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A cluster of broadly neutralizing IgG against BK polyomavirus in a repertoire dominated by IgM;Life Science Alliance;2023-01-30

2. Therapeutic Potential of Exploiting Autophagy Cascade Against Coronavirus Infection;Frontiers in Microbiology;2021-05-14

3. The humoral response to BK polyomavirus in kidney transplant recipients is dominated by IgM antibodies that use a distinct repertoire compared to IgG against the same antigen;2021-02-09

4. Persistent BK Polyomavirus Viruria Is Associated with Accumulation of VP1 Mutations and Neutralization Escape;Viruses;2020-07-29

5. An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy?;Frontiers in Pharmacology;2020-05-29